Kutai Clay Granules for Reducing Escherichia coli and Coliform Bacteria in Hospital Wastewater
Blego Sedionoto, Wahyu Wahyu, Syamsir Syamsir, Nur Azijah Janatil Alyah, Idhar A. Jumlan, Rina Dwi Urbaningrum, Yuliana Yuliana, Dwi Ermawati Rahayu, Riyan Ningsih, Ayudhia Rachmawati
Journal of Advances in Microbiology · pp. 24–30 · Published 10 Oct 2026
10.9734/jamb/2026/v26i111211Abstract
Aims: This study evaluated the capacity of activated Kutai clay granules to reduce Escherichia coli and coliform bacteria in hospital wastewater and to characterise the clay by particle composition and cation-exchange capacity (CEC). Study Design: Laboratory experimental study comparing untreated hospital wastewater with four Kutai clay doses. Place and Duration of Study: Hospital wastewater was obtained from Abdoel Wahab Sjahranie Hospital, Samarinda, Indonesia, and laboratory analyses were performed using facilities associated with Mulawarman University. The study period was not reported in the source manuscript. Methodology: Activated Kutai clay granules were heated at 121°C for 30 minutes. Four doses (2.5, 5.0, 7.5, and 10.0 g) were separately added to 100 mL of hospital wastewater. Samples were stirred at 2500 rpm for 5 minutes and allowed to settle for 1–3 minutes. E. coli and coliform concentrations were measured using the Most Probable Number (MPN) method. Clay particle composition and CEC were also determined. Results: Kutai clay contained 59.0% clay, 26.0% silt, and 15.0% fine sand, with a reported CEC of 19.03 meq/100 g. Untreated wastewater contained 1.1 × 10⁵ MPN/100 mL of both E. coli and coliform bacteria. After treatment, all four clay doses produced a reported concentration of 3.0 × 10² MPN/100 mL for both indicators, corresponding to 99.73% removal. No dose-response difference was observed in the reported measurements. Conclusion: Under the reported laboratory conditions, Kutai clay granules substantially reduced E. coli and coliform concentrations in hospital wastewater. Because all tested doses yielded the same reported endpoint, the lowest dose (2.5 g/100 mL) may warrant further evaluation for treatment efficiency. Replicated experiments, statistical analysis, and physicochemical characterisation are needed before scale-up or routine application.
Cited by 0
No indexed citations yet.
Related research
- Antibacterial Activity of Bidens pilosa Extracts on Escherichia coli O157: H7 Isolated from Apparently Healthy Individuals — shares topic coverage
- Urine Analysis and Determination of Drug Sensitivity Pattern of Isolated Escherichia coli from Urinary Tract Infected Patients — shares topic coverage
- Evaluation of the Effects of Pediococcus acidilactici Isolated from Wara, a Nigerian Milk Product, in the Prevention of Diarrhea and the Modulation of Intestinal Microflora in Wistar Rats — shares topic coverage
- Prevalence, Aetiological Agents and Antimicrobial Resistance Patterns of Urinary Tract Infections among Pregnant Women Attending Mother and Child Hospital, Akure, South-West Nigeria — shares topic coverage
- Molecular Detection of the Arr-2 Gene in Escherichia coli and Klebsiella pneumoniae Resistant to Rifampicin in Abidjan, Côte D'Ivoire — shares topic coverage
Article metrics
Real usage data collected on this platform.
12
Page views
0
PDF downloads
1
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.